《外围股市》美股期货全面急升2.4%-3.7% 道指期货追落後曾飙升920点
美国连日主要经济数据均剧跌兼远差预期,但美国总统特朗普向各州发布分阶段取消家居令和放松社交距离限制指引,意味着美国即将重启经济活动,加上据报有药物或可治疗新冠肺炎,纾缓市场对疫情将会进一步冲击经济忧虑。美股期货全面急升2.4%-3.7%,道指期货发力追落後,曾急涨920点,最高见24,327,现造24,274,急涨867点或3.7%;标普五百期货及纳指一百期货分别高见2,885及8,966,现造2,881及8,941,急涨94点或3.4%及207点或2.4%。
有医药新闻网站报道,美国药厂吉利德研发的新抗病毒药物「瑞德西韦」被芝加哥大学实验显示,新冠肺炎病人服用该药物後,不少人很快有正面疗效。吉利德回应,暂时未有足够数据证实疗效,本月底会取得更多数据作为研究。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.